Crohn's disease in adolescents

Bailliere's Clinical Gastroenterology

Volumn 12, Issue 1, 1998, Pages 115-132

  Griffiths, Anne M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adolescents; Crohn's disease

Indexed keywords

CORTICOSTEROID; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CLINICAL FEATURE; CROHN DISEASE; DELAYED PUBERTY; ENTERIC FEEDING; ENTERITIS; GROWTH INHIBITION; HUMAN; INTESTINE RESECTION; NUTRITION; NUTRITIONAL DEFICIENCY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMALL INTESTINE OBSTRUCTION;

EID: 0031844341     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(98)90088-4     Document Type: Article

References (64)

1. Aiges H, Markowitz J, Rosa J & Daum F (1989) Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology 97: 905-910.
2. Azcue M, Rashid M, Griffiths AM & Pencharz P (1997) Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and prednisone treatment. Gut 41: 203-208.
3. Barton JR & Ferguson A (1990) Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Quarterly Journal of Medicine 75(277): 423-439.
4. Belli D, Seidman EG, Bouthillier L et al (1988) Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 94: 603-610.
5. Castile RG, Telander RL, Cooney DR et al (1980) Crohn's disease in children: assessment of the progression of disease, growth and progress. Journal of Pediatric Surgery 15: 462-469.
6. Chan ATH, Fleming CR, O'Fallon WM et al (1986) Estimated versus basal energy requirements in patients with Crohn's disease. Gastroenterology 91: 75-78.
7. Connell WR, Kamm MA, Dickson M et al (1994) Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343: 1249-1252.
8. Cuffari C, Theoret Y, Latour S & Seidman EG (1996) 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut 39: 401-406.
9. Davies G, Evans CM, Shand WS & Walker-Smith JA (1990) Surgery for Crohn's disease in childhood: influence of site of disease and operative procedure on outcome. British Journal of Surgery 77: 891-894.
10. DeBenedetti F, Alonzi T, Moretta A et al (1997) Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-1. A model for stunted growth in children with chronic inflammation. Journal of Clinical Investigation 99: 643-650.
11. Feagan BG, McDonald JW, Rochon J et al (1994) Low-dose cyclosporine for the treatment of Crohn's disease. New England Journal of Medicine 330: 1846-1851.
12. Fernandez-Banares F, Cabre E, Gonzalez-Huix F & Gassull MA (1994) Enteral nutrition as primary therapy in Crohn's disease. Gut 35: S55-S59.
13. Fernandez-Banares F, Cabre E, Esteve-Comas M & Gassull MA (1995) How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. Journal of Parenteral and Enteral Nutrition 19: 356-362.
14. Filipsson S, Hulten L & Lindstedt G (1978) Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease. Scandinavian Journal of Gastroenterology 13: 529-536.
15. Greenberg GR, Feagan BG, Martin F et al (1994) Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. New England Journal of Medicine 331: 836-841.
16. Griffiths AM (1992) Crohn's disease. In David TJ (ed.) Recent Advances in Paediatrics, No. 10, pp 145-160. Edinburgh: Churchill Livingstone.
17. Griffiths AM (1996) Medical management of Crohn's disease in the paediatric population. In McLeod RS, Martin F, Sutherland LR, Wallace JL & Williams CN (eds) Trends in Inflammatory Bowel Disease Therapy, pp 191-199. Lancaster, UK: Kluwer Academic Publishers.
18. Griffiths AM, Drobnies A, Soldin SJ & Hamilton JR (1986) Enteric protein loss measured by fecal alpha-1-antitrypsin clearance in the assessment of Crohn's disease activity. Journal of Pediatric Gastroenterology and Nutrition 5: 907-910.
19. Griffiths AM., Ohlsson A, Sherman PM & Sutherland LR (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 108: 1056-1067.
20. Griffiths AM, Wesson DE, Shandling B et al (1991) Factors influencing the postoperative recurrence of Crohn's disease in childhood. Gut 32: 491-495.
21. Griffiths AM, Koletzko S, Sylvester F et al (1993a) Oral 5-aminosalicylic acid in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition 17: 186-192.
22. Griffiths, AM, Nguyen P, Smith C et al (1993b) Growth and clinical course of children with Crohn's disease. Gut 34: 939-943.
23. Halligan S, Nicholls S, Bartram CI & Walker-Smith JA (1994) The distribution of small bowel Crohn's disease in children compared to adults. Clinical Radiology 49: 314-316.
24. Hildebrand H, Karlberg J & Kristiansson B (1994) Longitudinal growth in children and adolescents with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 18: 165-173.
25. Hofley P, Roarty J, McGinnity G et al (1993) Asymptomatic uveitis in children with chronic inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 17: 397-400.
26. Homer DR, Grand R & Coloduy AH (1977) Growth, course and prognosis after surgery for Crohn's disease in childhood. Pediatrics 59: 717-725.
27. Hyams JS (1994) Extraintestinal manifestations of inflammatory bowel disease in children. Journal of Pediatric Gastroenterology and Nutrition 19: 7-21.
28. Israel OM & Hassall E (1995) Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn's disease. American Journal of Gastroenterology 90: 1084-1088.
29. Kanof ME, Lake AM & Bayless TM (1988) Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 95: 1423-1527.
30. Kaplowitz PB (1995) Effect of growth hormone therapy on final versus predicted height in short twelve- to sixteen-year-old boys without growth hormone deficiency. Journal of Pediatrics 126: 478-480.
31. Kelts DG, Grand RJ, Shen G et al (1979) Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastroenterology 76: 720-727.
32. Kirschner BS (1990) Growth and development in chronic inflammatory bowel disease. Acta Paediatrica Scandinavica 366S: 98-104.
33. Kirschner BS & Sutton MM (1986) Somatomedin-C levels in growth impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91: 830-836.
34. Lennard L & Lilleyman JS (1989) Variable 6-mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. Journal of Clinical Oncology 7: 1816-1823.
35. Lochs H, Steinhardt HJ, Klaus-Wentz B et al (1991) Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study IV. Gastroenterology 101: 881-888.
36. Löfberg R, Rutgeerts P, Malchow H et al (1996) Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut 39: 82-86.
37. Malchow H, Ewe K, Brandes JW et al (1984) European Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 86: 249-266.
38. Malchow H, Steinhardt HJ, Lorenz-Meyer H et al (1990) European Cooperative Crohn's Disease Study III. Scandinavian Journal of Gastroenterology 25: 235-244.
39. Markowitz J, Rosa J, Grandier K et al (1990) Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology 99: 1347-1351.
40. Markowitz J, Grancher K, Rosa J et al (1993) Growth failure in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 16: 373-380.
41. Messori G, Trallori G, D'Albasio G et al (1996) Defined-formula diets versus steroids in the treatment of active Crohn's disease. A meta-analysis. Scandinavian Journal of Gastroenterology 31: 267-272.
42. Motil KJ, Grand RJ, Davis-Kraft L et al (1993) Growth failure in children with inflammatory bowel disease: A prospective study. Gastroenterology 105: 681-691.
43. Murch SH (1995) Inflammatory mediators and suppression of growth in paediatric chronic IBD. In Tytgat GNJ, Bartelsman JFWM & van Deventer SJH (eds) Inflammatory Bowel Diseases, pp 598-603. Dordrecht, The Netherlands: Kluwer Academic Publishers.
44. Neely EK & Rosenfeld RG (1994) Use and abuse of human growth hormone. Annual Review of Medicine 45: 407-420.
45. Pearson DC, May GR, Fick GH & Sutherland LR (1995) Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis. Annals of Internal Medicine 122: 132-142.
46. Present DH, Meltzer SJ, Krumholz NW et al (1989) 6-Mercaptopurine in the management of inflammatory bowel diseases: short and long-term toxicity. Annals of Internal Medicine 111: 641-649.
47. Richman R & Kirsch LR (1988) Testosterone treatment in adolescent boys with constitutional delay in growth and development. New England Journal of Medicine 319: 1563-1567.
48. Rigaud D, Cosnes J, Le Quintrec Y et al (1991) Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease. Gut 32: 1492-1497.
49. Rosen A, Ursing B, Alm T et al (1982) Comparative study of metronidazole and sulphasalazine for active Crohn's disease: The Cooperative Crohn's Disease Study in Sweden. II. Result. Gastroenterology 83: 550-562.
50. Rutgeerts P, Geboes K, Vantrappen G et al (1984) Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 25: 665-672.
51. Rutgeerts P, Löfberg R, Malchow H et al (1994) A comparison of budesonide with prednisolone for active Crohn's disease. New England Journal of Medicine 331: 842-845.
52. Seidman E, Jones A, Issenman R & Griffiths A (1996) Relapse prevention/growth enhancement in paediatric Crohn's disease: multicentre randomized controlled trial of intermittent enteral nutrition versus alternate day prednisone. Journal of Pediatric Gastroenterology and Nutrition 23: 344A.
53. Seidman E, Leleiko N, Ament M et al (1991) Nutritional issues in paediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 12: 424.
54. Seidman E, Griffiths A, Issenman R et al (1993) Semi-elemental diet versus prednisone in the treatment of acute Crohn's disease in children and adolescents. Gastroenterology 104: A778.
55. Singleton JW, Hanauer SB, Gitnick GL et al (1994) Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Gastroenterology 104: 1293-1301.
56. Sutherland LR, Singleton J, Sessions J et al (1991) Double-blind, placebo-controlled trial of metronidazole in Crohn's disease. Gut 32: 1071-1075.
57. Tanner JM, Whitehouse RH & Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity. Archives of Disease in Childhood 41: 613-635.
58. Teahon K, Smethurst P, Pearson M et al (1991) The effect of elemental diet on permeability and inflammation in Crohn's disease. Gastroenterology 101: 84-89.
59. Thomas AG, Holly JMP, Taylor F & Miller V (1993). Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 34: 944-947.
60. Verhave M, Winter HS & Grand RJ (1990) Azathioprine in the treatment of children with inflammatory bowel disease. Journal of Pediatrics 117: 809-814.
61. Walker-Smith JA (1996) Management of growth failure in Crohn's disease. Archives of Diseases in Childhood 75: 351-354.
62. Whitington PF, Barnes V & Bayless TM (1977) Medical management of Crohn's disease in adolescence. Gastroenterology 72: 1338-1344.
63. Wilschanski M, Chait P, Wade JA et al (1995) Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 22: 1415-1422.
64. Wilschanski M, Sherman P, Pencharz P et al (1996) Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38: 543-548.